Specifically, this analysis indicated that TRIM8 expression was higher in leukemia and prostate cancer, but was lower in breast cancer, esophageal cancer, lung cancer, melanoma, and sarcoma (Figure 2A). Here, TRIM8 is linked to Familial prostate cancer.